ABBV Aug 2022 165.000 put
| Previous close | 15.13 |
| Open | 14.35 |
| Bid | 14.35 |
| Ask | 15.00 |
| Strike | 165.00 |
| Expiry date | 2022-08-19 |
| Day's range | 14.35 - 14.35 |
| Contract range | N/A |
| Volume | |
| Open interest | 208 |
- Motley Fool
These 5 Top Stocks Are Set to Outperform in a Recession
The Federal Reserve is grappling with elevated inflation by taking a hawkish stance and raising interest rates. Sprinkle in solid growth companies whose stock has fallen out of favor, yet for which the secular bull case remains intact.
- Zacks
AbbVie (ABBV) Gains But Lags Market: What You Should Know
AbbVie (ABBV) closed the most recent trading day at $153.93, moving +0.08% from the previous trading session.
- Motley Fool
This Blockbuster Drug from AbbVie Is Closer to Another Major Indication
The European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) recently adopted a positive opinion that recommended the approval of AbbVie's (NYSE: ABBV) Rinvoq for what would be its fifth indication in that market. This would be to treat patients with moderate-to-severe ulcerative colitis who had an inadequate response to conventional therapies or biologic agents. A decision for Rinvoq as a treatment for moderate-to-severe ulcerative colitis patients from the European Commission is expected in the third quarter of this year.
